ADARx Pharmaceuticals, Inc. (ADRX) vs Allient Inc. (ALNT)

A side-by-side comparison of ADARx Pharmaceuticals, Inc. and Allient Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ADRX

ADARx Pharmaceuticals, Inc.

$1.95B

$19.05IndustrialsDelayed quote: Oct 5, 2026, 4:00 PM EDT

ALNT

Allient Inc.

$2.02B

$118.63IndustrialsDelayed quote: Oct 5, 2026, 4:00 PM EDT

Total return — ADRX vs ALNT

growth of $100 · dividends reinvested · last 1y

ADRX -1.6% (-1.6%/yr)ALNT +19.7% (+19.7%/yr)ALNT compounded faster over this window

ADRX ALNT

Metrics side by side

Total return (annualized)

Metric	ADRX	ALNT
Total return (1Y)	N/A	170.57%
Total return CAGR (3Y)	N/A	59.45%
Total return CAGR (5Y)	N/A	30.06%
Total return CAGR (10Y)	N/A	20.17%

ADRX is an index fund, so valuation, profitability, and per-company growth metrics don't apply — the head-to-head here is total return (price plus reinvested dividends).

Go deeper

Full ADRX analysis Full ALNT analysis Interactive comparison tool

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.